We are live on ! Find out more

QT Imaging Holdings

QTI

Market cap $32.1M

2.19 USD

+0.03

1.39%

At close Updated Nov 4, 4:00 PM EST

1 day

1.39%

5 days

-0.9%

1 month

-16.09%

3 months

-19.78%

6 months

-66.46%

Year to date

-63.44%

1 year

-63.44%

5 years

-77.83%

10 years

-77.83%

About: QT Imaging Holdings Inc. is a medical device company engaged in the research, development, and commercialization of body imaging systems using low frequency sound waves. Its medical imaging is critical to the detection, diagnosis, and treatment of disease. The company offers two products: QT Breast Scanner and QTviewer.

Employees: 32

Healthcare Medical Devices

News

Positive

Neutral

Negative

Sentiment 3-Months

Positive 0%

Neutral 100%

Negative 0%

QT Imaging to Report Third Quarter 2026 Financial Results and Host Conference Call on November 10, 2026

PETALUMA, Calif.--(BUSINESS WIRE)---- $QTI #BreastCancer--QT Imaging Holdings, Inc. (Nasdaq: QTI) (“QT Imaging” or the “Company”), a medical device company dedicated to transforming breast health management through innovative, radiation-free imaging technology, today announced that it will report financial results for the third quarter ended September 30, 2026, after market close on Tuesday, November 10, 2026, and will host a conference call beginning at 4:30 p.m. Eastern Time. Participants are encouraged to pre-regi.

QT Imaging to Report Third Quarter 2026 Financial Results and Host Conference Call on November 10, 2026

QT Imaging's Breast Acoustic CT™ Scanner Now Available Through National Group Purchasing Agreement with Premier

NOVATO, Calif.--(BUSINESS WIRE)--QT Imaging Holdings, Inc. (Nasdaq: QTI) (“QT Imaging” or the “Company”), a medical device company dedicated to transforming breast health management through innovative, radiation-free imaging technology, today announced that its U.S. distribution partner, NXC Imaging, Inc., a wholly owned subsidiary of Canon Medical Systems USA, Inc., has entered into a national group purchasing agreement with Premier, Inc. covering the QTI Breast Acoustic CT™ scanner and provid.

QT Imaging's Breast Acoustic CT™ Scanner Now Available Through National Group Purchasing Agreement with Premier

QT Imaging Announces CPT® Category III Code for 3D Breast Acoustic Imaging Now Effective

NOVATO, Calif.--(BUSINESS WIRE)---- $QTI #BreastCancer--QT Imaging Holdings, Inc. (Nasdaq: QTI) (“QT Imaging” or the “Company”), a medical device company dedicated to transforming breast health management through innovative, radiation-free imaging technology, today announced that CPT® Category III code 1079T for 3D quantitative transmission water bath volumetric ultrasound tomography of the breast is effective for dates of service beginning October 1, 2026. The code is effective for use three months earlier than the.

QT Imaging Announces CPT® Category III Code for 3D Breast Acoustic Imaging Now Effective

QT Imaging to Ring the Nasdaq Closing Bell on October 2 in Recognition of Breast Cancer Awareness Month

NOVATO, Calif.--(BUSINESS WIRE)---- $QTI #BreastCancer--QT Imaging Holdings, Inc. (Nasdaq: QTI) (“QT Imaging” or the “Company”), a medical device company dedicated to transforming breast health management through innovative, radiation-free imaging technology, today announced that Chief Executive Officer Dr. Raluca Dinu will ring the Nasdaq Stock Market Closing Bell on October 2, 2026, in recognition of Breast Cancer Awareness Month. She will be joined by QT Imaging's executive leadership, team members, and key partne.

QT Imaging to Ring the Nasdaq Closing Bell on October 2 in Recognition of Breast Cancer Awareness Month

QT Imaging to be Honored at Premier's Annual Supplier Innovation Celebration

NOVATO, Calif.--(BUSINESS WIRE)---- $QTI #BreastCancer--QT Imaging Holdings, Inc. (Nasdaq: QTI) (“QT Imaging” or the “Company”), a medical device company dedicated to transforming breast health management through innovative, radiation-free imaging technology, today announced it will be honored during Premier's annual Supplier Innovation Celebration at its 2026 Breakthroughs Conference and Exhibition, taking place October 6-8, 2026. The Innovation Celebration recognizes groundbreaking healthcare technologies launched.

QT Imaging to be Honored at Premier's Annual Supplier Innovation Celebration

QT Imaging Appoints Imaging Industry Veteran Dr. Mark Winkler as Chief Medical Officer

NOVATO, Calif.--(BUSINESS WIRE)---- $QTI #BreastCancer--QT Imaging Holdings, Inc. (Nasdaq: QTI) (“QT Imaging” or the “Company”), a medical device company dedicated to transforming breast health management through innovative, radiation-free imaging technology, today announced the appointment of Mark L. Winkler, M.D., as Chief Medical Officer (CMO). “Mark has the perspective of an accomplished radiologist along with the experience of an entrepreneur who has built and scaled a very successful imaging organization,” said.

QT Imaging Appoints Imaging Industry Veteran Dr. Mark Winkler as Chief Medical Officer

QT Imaging Holdings, Inc. (QTI) Presents at IAccess Alpha Virtual Best Ideas Fall Investment Conference 2026 Transcript

QT Imaging Holdings, Inc. (QTI) Presents at IAccess Alpha Virtual Best Ideas Fall Investment Conference 2026 Transcript

QT Imaging Holdings, Inc. (QTI) Presents at IAccess Alpha Virtual Best Ideas Fall Investment Conference 2026 Transcript

QT Imaging to Participate in the iAccess Alpha Virtual Best Ideas Fall Investment Conference

NOVATO, Calif.--(BUSINESS WIRE)---- $QTI #BreastCancer--QT Imaging Holdings, Inc. (Nasdaq: QTI) (“QT Imaging” or the “Company”), a medical device company dedicated to transforming breast health management through innovative, radiation-free imaging technology, today announced its participation in the iAccess Alpha Virtual Best Ideas Fall Investment Conference 2026, taking place September 15–16, 2026. Chief Financial Officer Jay Jennings will deliver a company presentation at 3:30 pm ET on September 15, followed by one.

QT Imaging to Participate in the iAccess Alpha Virtual Best Ideas Fall Investment Conference

QT Imaging Issues Mid-Year 2026 CEO Letter to Shareholders

NOVATO, Calif.--(BUSINESS WIRE)---- $QTI #BreastCancer--QT Imaging Holdings, Inc. (Nasdaq: QTI) (“QT Imaging” or the “Company”), a medical device company dedicated to transforming breast health management through innovative, radiation-free imaging technology, today issued a mid-year 2026 letter to shareholders from its CEO, Dr. Raluca Dinu. The full text of the letter appears below and at this link which can be found on the QT Imaging website. Dear Fellow Shareholders, I am energized by QT Imaging's many accomplishme.

QT Imaging Issues Mid-Year 2026 CEO Letter to Shareholders

QT Imaging Holdings, Inc. (QTI) Q2 2026 Earnings Call Transcript

QT Imaging Holdings, Inc. (QTI) Q2 2026 Earnings Call Transcript

QT Imaging Holdings, Inc. (QTI) Q2 2026 Earnings Call Transcript

See News Rankings

Price charts implemented using Lightweight Charts™